SMT201300059B - Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione - Google Patents

Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Info

Publication number
SMT201300059B
SMT201300059B SM201300059T SM201300059T SMT201300059B SM T201300059 B SMT201300059 B SM T201300059B SM 201300059 T SM201300059 T SM 201300059T SM 201300059 T SM201300059 T SM 201300059T SM T201300059 B SMT201300059 B SM T201300059B
Authority
SM
San Marino
Prior art keywords
biopolymer
incorporating
production
acid produced
fusidic acid
Prior art date
Application number
SM201300059T
Other languages
English (en)
Inventor
Vanangamudi Subramaniam Sulur
Madhavan Srinivasan
Neelakandan Narayanan Chulliel
Kuppusamy Senthilkumar
Original Assignee
Vanangamudi Subramaniam Sulur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanangamudi Subramaniam Sulur filed Critical Vanangamudi Subramaniam Sulur
Publication of SMT201300059B publication Critical patent/SMT201300059B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201300059T 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione SMT201300059B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN960MU2009 2009-04-13
PCT/IB2010/051552 WO2010119385A1 (en) 2009-04-13 2010-04-12 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it

Publications (1)

Publication Number Publication Date
SMT201300059B true SMT201300059B (it) 2013-07-09

Family

ID=42558569

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300059T SMT201300059B (it) 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Country Status (19)

Country Link
US (1) US8895542B2 (it)
EP (1) EP2419087B1 (it)
JP (1) JP5205549B2 (it)
KR (1) KR101642537B1 (it)
CN (1) CN102159191B (it)
BR (1) BRPI1006729B1 (it)
CA (1) CA2795611C (it)
CY (1) CY1113885T1 (it)
DK (1) DK2419087T3 (it)
ES (1) ES2404156T3 (it)
HR (1) HRP20130149T1 (it)
IL (1) IL215641A (it)
MX (1) MX2011010784A (it)
PL (1) PL2419087T3 (it)
PT (1) PT2419087E (it)
RU (1) RU2537023C2 (it)
SI (1) SI2419087T1 (it)
SM (1) SMT201300059B (it)
WO (1) WO2010119385A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
WO2014144423A2 (en) * 2013-03-15 2014-09-18 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
WO2017091167A1 (en) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone
CN107224426A (zh) * 2017-07-08 2017-10-03 天津双硕医药科技有限公司 一种含有夫西地酸的外用乳膏组合物
CN111012747B (zh) * 2018-10-10 2022-11-25 四川海思科制药有限公司 一种注射用夫西地酸钠药物组合物及其制备方法
CN114432250B (zh) * 2022-02-22 2022-10-04 深圳市泰力生物医药有限公司 一种非晶态夫西地酸的稳定方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
SU1380751A2 (ru) * 1986-03-12 1988-03-15 Всесоюзный научно-исследовательский институт антибиотиков Средство дл лечени гнойно-воспалительных заболеваний кожи и м гких тканей
DK603988D0 (da) * 1988-10-28 1988-10-28 Klaus Bendtzen Farmaceutisk praeparat
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
DK1032378T3 (da) * 1997-11-25 2002-04-15 Yamanouchi Europ Bv Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
ES2204331B1 (es) * 2002-10-09 2005-03-01 Ercros Industrial, S.A. Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion.
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
JP2007529464A (ja) * 2004-03-16 2007-10-25 グラクソ グループ リミテッド ビラゾロ[3,4−b]ピリジン化合物及びPDE4阻害剤としてのその使用
CN101378728A (zh) * 2006-02-02 2009-03-04 利奥制药有限公司 包含抗菌物质的局部用组合物
US9132071B2 (en) 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
US20110257144A1 (en) * 2008-12-19 2011-10-20 Apex Laboratories Private Limited Novel dermaceutical cream made using sodium fusidate
RU2536426C2 (ru) * 2009-02-18 2014-12-20 Сулур Субраманиам ВАНАНГАМУДИ Способ изготовления крема, содержащего фусидовую кислоту

Also Published As

Publication number Publication date
KR101642537B1 (ko) 2016-07-25
RU2537023C2 (ru) 2014-12-27
BRPI1006729B1 (pt) 2021-10-05
EP2419087B1 (en) 2013-01-23
MX2011010784A (es) 2012-01-12
RU2011146230A (ru) 2013-05-20
ES2404156T3 (es) 2013-05-24
CA2795611C (en) 2016-09-20
CN102159191A (zh) 2011-08-17
JP5205549B2 (ja) 2013-06-05
CY1113885T1 (el) 2016-07-27
IL215641A (en) 2014-09-30
US8895542B2 (en) 2014-11-25
CN102159191B (zh) 2014-04-02
US20120040946A1 (en) 2012-02-16
IL215641A0 (en) 2012-01-31
EP2419087A1 (en) 2012-02-22
SI2419087T1 (sl) 2013-06-28
KR20120023653A (ko) 2012-03-13
DK2419087T3 (da) 2013-05-06
HRP20130149T1 (hr) 2013-03-31
BRPI1006729A2 (pt) 2020-10-06
PL2419087T3 (pl) 2013-06-28
WO2010119385A1 (en) 2010-10-21
JP2012523451A (ja) 2012-10-04
PT2419087E (pt) 2013-04-26
CA2795611A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
SMT201300059B (it) Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione
EP2463281A4 (en) PROCESS FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF
FR2948364B1 (fr) Procede de preparation d'un fluorure d'halogenoacetyle et de ses derives
EP2545178A4 (en) ACIDIFICATION BY FERMENTATION
BRPI1015297A2 (pt) "método para a preparação de produtos de clivagem de carboidratos a partir de um material lignocelulósico".
SMT201500204B (it) Procedimento per preparare un acido bivenil-2-il carbammico
BRPI1012875A2 (pt) composições farmacêuticas sólidas e processos para sua produção
BR112012024034A2 (pt) produto de confeitaria e métodos de sua produção
DK2482881T3 (da) Mekanisme til indretning til indlevering af lægemiddel
DK3329783T3 (da) Fremgangsmåde til fremstilling af et syrnet mælkeprodukt
HK1168588A1 (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)- cyclopropanecarboxylic acid 1-(2--4-)-
GB2476288B (en) A method of manufacturing a medicinal product
FI20080348A0 (fi) Uudenlainen farmaseuttinen formulaatio
BRPI0920124A2 (pt) produto farmacêutico para aumentar a dose de vacina contra alergia
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
HUP1000444A2 (en) Process for the preparation of a pharmaceutical active ingredient
WO2010134048A3 (en) Topical retinoid solutions
HRP20130515T1 (en) A process to make fusidic acid cream
IL215550A0 (en) Process for the preparation of a biphenyl-2-ylcarbamic acid ester
EP2793877A4 (en) GUM EXTRACTS WITH [(2-ISOPROPYL-5-METHYL-CYCLOHEXANCARBONYL-) AMINO-] ACETIC ACID ISOPROPYLESTER
BRPI1010748A2 (pt) comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico.
FR2957345B1 (fr) Procede de preparation d'un radiotraceur
DOP2009000001A (es) Composicion farmaceutica que contiene un acido tetrahidrofolico.
TH117359B (th) วิธีผลิต 5'-กรดกัวนีลิก
PT2659895T (pt) Composição farmacêutica contendo ácido hialurónico e um composto de zinco e a correspondente pastilha com pauzinho e processo para a sua preparação